ANI Pharmaceuticals (ANIP) had the highest return in 2014 by a US stock in the Pharmaceuticals Industry, returning 180.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
ANI Pharmaceuticals (ANIP) | 2014 | 180.83% |
Harrow Health (HROW) | 2014 | 127.27% |
Omeros (OMER) | 2014 | 120.46% |
Avadel Pharmaceuticals (AVDL) | 2014 | 112.53% |
Aurora Cannabis (ACB) | 2014 | 100.45% |
Phibro Animal Health (PAHC) | 2014 | 92.85% |
Ocular Therapeutix (OCUL) | 2014 | 80.92% |
Amphastar P (AMPH) | 2014 | 65.86% |
Pacira BioSciences (PCRX) | 2014 | 54.43% |
CorMedix (CRMD) | 2014 | 54.03% |
Assertio Therapeutics (ASRT) | 2014 | 53.43% |
Teva Pharma Industries Ltd ADR (TEVA) | 2014 | 47.58% |
Eli Lilly and (LLY) | 2014 | 39.83% |
Opus Genetics (IRD) | 2014 | 37.25% |
Nektar Therapeutics (NKTR) | 2014 | 37.05% |
Zoetis (ZTS) | 2014 | 33.45% |
Viatris (VTRS) | 2014 | 29.94% |
Jazz Pharmaceuticals (JAZZ) | 2014 | 29.18% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2014 | 26.11% |
AstraZeneca PLC ADR (AZN) | 2014 | 25.24% |
Dr Reddy’s Laboratories Ltd ADR (RDY) | 2014 | 24.65% |
Bausch Health Companies (BHC) | 2014 | 22.32% |
Novartis AG ADR (NVS) | 2014 | 21.47% |
KING PHARMACEUTICALS (KG) | 2014 | 20.28% |
Johnson & Johnson (JNJ) | 2014 | 17.92% |
